Health ❯Healthcare ❯Patient Care ❯Chronic Conditions

Obesity Management

UK ‘Postcode Lottery’ for Weight-Loss Jabs Persists as Generics Line Up for 2026

Patchy NHS access meets looming overseas generics, raising price pressure plus safety risks for UK patients.

Orforglipron Pill Cuts Weight 11–12% in Pivotal Phase 3 Trial

Eli Lilly’s Oral Obesity Pill Triggers Stock Slide After Modest Weight-Loss Results